Starna Therapeutics

About:

Starna Therapeutics developing tissue selective targeted RNA therapies for unmet patient needs.

Website: http://www.starnatx.com

Top Investors: Hillhouse Investment, Source Code Capital, GL Ventures LLC, Primavera Capital Group, LYFE Capital

Description:

Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.

Total Funding Amount:

$32.1M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2021-08-01

Contact Email:

info(AT)starnatx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-05-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai